Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Chinese Medical Sciences Journal ; (4): 331-339, 2022.
Artículo en Inglés | WPRIM | ID: wpr-970699

RESUMEN

Objective To investigate the expression of topoisomeraseⅡα (TOP2α) in hepatocellular carcinoma (HCC) and its role in predicting prognosis of HCC patients. Methods We used HCC-related datasets in UALCAN, HCCDB, and cBioPortal databases to analyze the expression and mutation of TOP2α and its co-expressed genes in HCC tissues. GO function and KEGG pathway enrichment of TOP2α and its co-expressed genes were identified. The TIMER database was used to analyze infiltration levels of immune cells in HCC. The impacts of TOP2α and its co-expression genes and the infiltrated immune cells on the survival of HCC patients were assayed by Kaplan-Meier plotter analysis. Results TOP2α and its co-expression genes were highly expressed in HCC (P< 0.001) and detrimental to overall survival of HCC patients (P< 0.001). TOP2α and its co-expression genes were mainly involved in cell mitosis and proliferation, and cell cycle pathway (ID: hsa04110, P = 0.001945). TOP2α and its co-expression genes were mutated in HCC and the mutations were significantly detrimental to overall survival (P = 0.0247) and disease-free survival (P = 0.0265) of HCC patients. High TOP2α expression was positively correlated with the infiltration of B cell (r = 0.459, P< 0.01), CD8+ T cell (r = 0.312, P< 0.01), CD4+ T cell (r = 0.370, P< 0.01), macrophage (r = 0.459, P< 0.01), neutrophil (r = 0.405, P< 0.01), and dendritic cell (r = 0.473, P< 0.01) in HCC. The CD8+ T cell infiltration significantly prolonged the 3- and 5-year survival of HCC patients (all P< 0.05), and CD4+ T cell infiltration significantly shortened the 3-, 5-, and 10-year survival of HCC patients (all P< 0.05). ConclusionTOP2α may be an oncogene, which was associated with poor prognosis of HCC patients and could be used as a biomarker for the prognostic prediction of HCC.


Asunto(s)
Humanos , Biomarcadores de Tumor/genética , Carcinoma Hepatocelular/genética , Linfocitos T CD8-positivos , Biología Computacional , Neoplasias Hepáticas/genética , Pronóstico , ADN-Topoisomerasas de Tipo II/genética
2.
Biomédica (Bogotá) ; 37(supl.2): 83-97, jul.-set. 2017. tab, graf
Artículo en Español | LILACS | ID: biblio-888528

RESUMEN

Resumen Introducción. La provincia de Pichincha, Ecuador, es un área endémica de leishmaniasis cutánea, en donde se han determinado como vectores los flebotomíneos antropofílicos con infección natural por Leishmania spp. Sin embargo, no se ha evaluado el papel en la transmisión de las especies zoofílicas. Objetivo. Evaluar la infección natural por Leishmania en dos especies de flebotomíneos zoofílicos, Lutzomyia reburra y Lu. barrettoi majuscula, y en una antropofílica, Lu. trapidoi, así como la endofagia y la sinantropía de estas especies en el noroccidente de Pichincha. Materiales y métodos. Los flebotomíneos se recolectaron en trampas de luz CDC colocadas en diferentes hábitats y altitudes en sitios que son focos de leishmaniasis cutánea. La infección con Leishmania spp. se detectó en el ADN genómico de hembras de las especies de flebotomíneos de interés. Se amplificó el gen espaciador interno de la transcripción del ARN ribosómico, unidad I (ITS1), y los genes de las topoisomerasas mitocondrial II (mtTOPOII) y nuclear II (TopoII). Se determinaron los porcentajes de positividad para Leishmania a escala espaciotemporal, la proporción de endofagia y el índice de sinantropía. Resultados. Se determinó la presencia de infección natural por Le. amazonensis en Lu. reburra (9,5 %) y Lu. b. majuscula (23,8 %); en Lu. trapidoi se detectaron Le. amazonensis, Le. brazilienis y Le. naiffilainsoni. Los flebotomíneos eran asinantrópicos y con baja endofagia. Conclusión. Se registró por primera vez la presencia de infección natural en Lu. reburra y Lu. barrettoi majuscula por Le. amazonensis, y se demostró la importancia de los flebotomíneos zoofílicos en el mantenimiento del ciclo de transmisión de Leishmania spp. en focos endémicos.


Abstract Introduction: The province of Pichincha in Ecuador is an endemic area of cutaneous leishmaniasis, where anthropophilic sand flies with natural infection by Leishmania, have been reported as vectors. However, the role in transmission of zoophilic species has not been evaluated. Objective: To evaluate natural infection by Leishmania in two zoophilic phlebotomine sand fly species, Lutzomyia reburra and Lu. barrettoi majuscula, and one anthropophilic species, Lu. trapidoi, as well as the endophagy and synanthropism of these species in the northwest of Pichincha. Materials and methods: Phlebotomines were collected using CDC light traps in different habitats and altitudes with presence of cutaneous leishmaniasis. Leishmania infection was detected using genomic DNA from females of the collected sand flies. We amplified the internal transcribed spacer gene of ribosomal RNA I (ITS1), the mitochondrial topoisomerase II gene (mtTOPOII), and the nuclear topoisomerase II gene (TopoII). Percentages of positivity for Leishmania, at spatio-temporal scale, proportion of endophagy and synanthropism index were calculated. Results: Natural infection was determined for Le. amazonensis in Lu. reburra (9.5%) and Lu. b. majuscula (23.8%), while in Lu. trapidoi we detected Le. amazonensis, Le. brazilienis and Le. naiffilainsoni. Phlebotomines were asynanthropic and with low endophagy. Conclusion: Natural infection with Le. amazonensis was recorded for the first time in Lu. reburra and Lu. b. majuscula, demonstrating the importance of zoophilic phlebotomines in the maintenance of the Leishmania transmission cycle in endemic foci.


Asunto(s)
Animales , Femenino , Psychodidae/parasitología , Leishmaniasis Cutánea/transmisión , Insectos Vectores/parasitología , Leishmania/aislamiento & purificación , Filogenia , Especificidad de la Especie , Proteínas Protozoarias/genética , Núcleo Celular/enzimología , ADN Protozoario/análisis , Leishmaniasis Cutánea/parasitología , ADN-Topoisomerasas de Tipo II/genética , ADN Espaciador Ribosómico/análisis , Ecuador , Conducta Alimentaria , Filogeografía , Leishmania/fisiología , Leishmania/genética , Mitocondrias/enzimología
3.
Yonsei Medical Journal ; : 188-191, 2011.
Artículo en Inglés | WPRIM | ID: wpr-136367

RESUMEN

Among 155 clinical respiratory isolates of Haemophilus influenzae in Korea, 6 (3.9%) isolates had reduced levofloxacin susceptibility (MICs > or = 0.5 microg/mL). These six isolates had no significant quinolone resistance-determining region (QRDR) mutations in gyrA, gyrB, parC, or parE. This phenomenon suggests that neither evolution nor spread of any significant QRDRs mutations in clinical isolates occurred in Korea. Therefore, continued surveillance is necessary to observe the evolution of antibiotic-resistance and take measures to avoid the spread of drug-resistant clones.


Asunto(s)
Antibacterianos/farmacología , Girasa de ADN/genética , ADN-Topoisomerasas de Tipo II/genética , Haemophilus influenzae/efectos de los fármacos , Corea (Geográfico) , Pruebas de Sensibilidad Microbiana , Mutación , Ofloxacino/farmacología
4.
Yonsei Medical Journal ; : 188-191, 2011.
Artículo en Inglés | WPRIM | ID: wpr-136366

RESUMEN

Among 155 clinical respiratory isolates of Haemophilus influenzae in Korea, 6 (3.9%) isolates had reduced levofloxacin susceptibility (MICs > or = 0.5 microg/mL). These six isolates had no significant quinolone resistance-determining region (QRDR) mutations in gyrA, gyrB, parC, or parE. This phenomenon suggests that neither evolution nor spread of any significant QRDRs mutations in clinical isolates occurred in Korea. Therefore, continued surveillance is necessary to observe the evolution of antibiotic-resistance and take measures to avoid the spread of drug-resistant clones.


Asunto(s)
Antibacterianos/farmacología , Girasa de ADN/genética , ADN-Topoisomerasas de Tipo II/genética , Haemophilus influenzae/efectos de los fármacos , Corea (Geográfico) , Pruebas de Sensibilidad Microbiana , Mutación , Ofloxacino/farmacología
5.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 458-60, 2005.
Artículo en Inglés | WPRIM | ID: wpr-634258

RESUMEN

To establish a simple, sensitive and effective technique for the identification of six common dermatophytes, polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (RFLP) targeting Topoisomerase II gene were used. The DNA of 6 common dermatophytes was amplified by primer dPsD1 and then primers dPsD2. The products generated by dPsD2 were digested with restriction enzyme Hinc II and Hinf I separately. A DNA fragment of about 3390 bp was amplified by using primer dPsD1 from the genomic DNA of each dermatophyte species. The product of dPsD2 was 2380 bp and the restriction profiles of Hinc II and Hinf I were between 58-1670 bp. By using PCR-RFLP, all of the 6 dermatophytoses were diagnosed to species level and no obvious difference identification between Hinc II and Hinf I. It is concluded that the PCR-RFLP identification of dermatophytes by Hinc II or Hinf I is efficient and rapid in clinical practice.


Asunto(s)
Arthrodermataceae/clasificación , Arthrodermataceae/genética , Arthrodermataceae/aislamiento & purificación , ADN-Topoisomerasas de Tipo II/genética , ADN de Hongos/análisis , ADN de Hongos/genética , Dermatomicosis/microbiología , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción
6.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 642-4, 2004.
Artículo en Inglés | WPRIM | ID: wpr-634297

RESUMEN

To find a fast and efficient way of identifying seven common dermatophytes in clinical practice, we used the techniques of polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (RFLP) targeting Topoisomerase II gene. The DNA of 7 dermatophytes, along with Candida albicans, Aspergillus terreus and Aspergillus flavus were amplified by consensus primer dPsD1. They were then subjected to a second PCR with primers dPsD2 and species-specific primers PsT and PsME separately. 6 of the products generated by dPsD2 were digested with restriction enzyme Hinc II. DNA fragments of 3390 bp and 2380 bp was amplified by using consensus primer dPsD1 and dPsD2 from the genomic DNA of each dermatophyte species separately. By combining the results of the two species-specific primer sets (PsT and PsME), all species of dermatophyte yielded unique sizes-set of PCR products expect for T. mentagrophytes and T. tonsurans. From the restriction profiles of Hinc II, 6 of the 7 dermatophytoses were diagnosed to species level including T. mentagrophytes and T. tonsurans. By combining the results of the PCR and PCR-RFLP, the 7 common dermatophytes can be identified to species level. It is conclude that the multiplex PCR and PCR-RFLP identification targeting the DNA topoisomerase II gene is rapid and efficient.


Asunto(s)
Arthrodermataceae/clasificación , Arthrodermataceae/aislamiento & purificación , Aspergillus/aislamiento & purificación , Candida albicans/aislamiento & purificación , ADN-Topoisomerasas de Tipo II/genética , Dermatomicosis/microbiología , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , Trichophyton/aislamiento & purificación
7.
Yonsei Medical Journal ; : 534-540, 1998.
Artículo en Inglés | WPRIM | ID: wpr-207246

RESUMEN

We analyzed the fluoroquinolone resistance mechanism of 28 isolates of ciprofloxacin-resistant E. coli from patients who received ciprofloxacin as a regimen of a selective gut decontamination. Isolates distinctive by infrequent restriction site polymerase chain reaction (IRS-PCR) were subjected to Hinf I restriction fragment length polymorphism analysis, single-stranded conformation polymorphism (SSCP), and nucleotide sequencing of the quinolone resistance determining region (QRDR) in gyrA. Double mutations in QRDR of gyrA (Ser83 Leu and Asp87Asn) were found from most of the strains. Nucleotide sequencing of the marR locus showed that 18 out of 28 (64%) ciprofloxacin-resistant E. coli strains had three types of base change in marR loci: a double-base change at nucleotides 1628 and 1751, or 1629 and 1751: and a single-base change at 1751. However, all the mutated strains showed no tolerance to cyclohexane test, suggesting the mutation in the marR region had no influence on overexpression of the MarA protein. In conclusion, mutation in gyrA was the main mechanism of ciporfloxacin resistance in E. coli from patients with selective gut decontamination. Therefore, mutation in the mar region did not influence the levels of ciprofloxacin resistance in our isolates.


Asunto(s)
Humanos , Ciprofloxacina/farmacología , ADN-Topoisomerasas de Tipo II/genética , Farmacorresistencia Microbiana/genética , Resistencia a Múltiples Medicamentos/genética , Escherichia coli/genética , Escherichia coli/efectos de los fármacos , Mutación/fisiología
8.
Yonsei Medical Journal ; : 541-545, 1998.
Artículo en Inglés | WPRIM | ID: wpr-207245

RESUMEN

Forty-one strains of Streptococcus pneumoniae were isolated at Seoul National University Children's Hospital from 1991 to 1997. Isolates were divided into six groups based on MICs of three quinolones, ciprofloxacin, ofloxacin and norfloxacin. Sequencing showed that the isolates which were intermediately resistant to three quinolones or resistant to at least one kind of quinolone had one missense mutation, Lys137-->Asn(AAG-->AAT) substitution in the ParC subunit of topoisomerase IV without additional mutation in QRDR of the GyrA subunit of DNA gyrase. In conclusion, the ParC subunit of DNA topoisomerase IV is the primary target site for fluoroquinolone in S. pneumoniae and Lys137-->Asn substitution renders the quinolone resistance in S. pneumoniae.


Asunto(s)
Humanos , ADN-Topoisomerasas de Tipo II/genética , Farmacorresistencia Microbiana/genética , Isoenzimas/genética , Mutación/genética , Quinolonas , Streptococcus pneumoniae/genética
9.
Indian J Exp Biol ; 1996 Oct; 34(10): 949-53
Artículo en Inglés | IMSEAR | ID: sea-61514

RESUMEN

Bacterial DNA gyrase enzyme plays a role in replication, transcription, recombination and repair. Escherichia coli gyrase enzyme is composed of two types of subunit, the gyr A and gyr B gene products called subunit A and B. Each type of subunit can be inhibited with temperature-sensitive mutations or by treating cells with specific antibiotic. Quinolones class of drugs such as nalidixic acid, oxonilic acid and norfloxacin affect gyr A protein. This effect due to inactivation of gyrase arises from the change in DNA superhelical tension. Mutant bacteria resistant to nalidixic acid show structural alterations in subunit A. Nalidixic acid resistant mutants of E. coli strains showed lower recombination efficiency, linkage, DNA repair, and mutation frequency than their wild types.


Asunto(s)
Antiinfecciosos/farmacología , Girasa de ADN , Reparación del ADN/efectos de los fármacos , ADN-Topoisomerasas de Tipo II/genética , Escherichia coli/efectos de los fármacos , Mutación , Ácido Nalidíxico/farmacología , Recombinación Genética/efectos de los fármacos
10.
Biol. Res ; 26(1/2): 77-80, 1993.
Artículo en Inglés | LILACS | ID: lil-228619

RESUMEN

The study of Trypanosoma cruzi type II DNA-topoisomerase should provide new clues for the rational development of new drugs for the chemotherapy of Chagas' disease. This enzyme is very likely involved in the processes leading to T. cruzi replication and differentiation since both processes are blocked by bacterial type II DNA topoisomerase inhibitors. In this article, we review and discuss our recent data related to the cloning, sequencing, and expression of T. cruzi type II topoisomerase


Asunto(s)
Animales , ADN-Topoisomerasas de Tipo II/metabolismo , Genes Protozoarios , Trypanosoma cruzi/enzimología , Secuencia de Aminoácidos , Enfermedad de Chagas/tratamiento farmacológico , Clonación Molecular , Crithidia fasciculata/enzimología , Crithidia fasciculata/genética , ADN-Topoisomerasas de Tipo II/genética , Datos de Secuencia Molecular , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Trypanosoma brucei brucei/enzimología , Trypanosoma brucei brucei/genética , Trypanosoma cruzi/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA